Search the CONFOCAL archive at
http://listserv.acsu.buffalo.edu/cgi-bin/wa?S1=confocal

We are pleased to announce the 2009 Quantitative Imaging Cytometry Course 
to be held on February 10, 11, and 12, 2009 at Cold Spring Harbor Laboratory. 

Registration and poster submission are now open at the Center’s website, 
www.imagingcytometrycenter.com.

Scientific presentations each morning will include the following:

Day 1 – Emergence of Quantitative Imaging Cytometry

•	Keynote presentation: The Science and Technology of Imaging 
Cytometry – J. Paul Robinson, SVM Professor of Cytomics, Professor of 
Immunopharmacology & Biomedical Engineering Director, Purdue University 
Cytometry Laboratories, W. Lafayette, IN and President, International Society 
for Analytical Cytology

•	Frontier Lecture: Capturing signaling events in the immune system in 
situ - Margaret Harnett, Professor of Immune Signaling, Division of 
Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, 
University of Glasgow, Scotland, UK

•	Laser Scanning Cytometry: An Expanding Role in Biomedical Imaging 
Analysis – William Telford, PhD, Director, Flow Cytometry Core Laboratory, 
National Cancer Institute, National Institutes of Health, Bethesda, MD

•	Investigation of a Role of a Protein Phosphatase in 
Neurodegeneration – Li Li, PhD, Cold Spring Harbor Laboratory, Cold Spring 
Harbor,  NY


Day 2 – Cell-Based Applications

•	Assessment of DNA Damage by High-Resolution Laser Scanning 
Cytometry – Zbigniew Darzynkiewicz, MD, PhD, Director, Brander Cancer 
Research Institute, Valhalla, NY

•	Regulation of Cell Cycle Transitions – James Jacobberger, PhD, 
Professor of Oncology, Case Western Reserve University, and Director, Cell 
Analysis Core, Case Comprehensive Cancer Center, Cleveland OH

•	Cell-Based Assays to Address Toxicology Issues in Pre-Clinical Drug 
Development Using Laser Scanning Cytometry – Padma Narayanan, PhD, 
Director, Investigative Toxicology, Amgen, Inc., Seattle, WA

•	Laser Scanning Cytometry Analysis of Rare Circulating Tumor Cells in 
Pre-Clinical Models of Cancer – Alison L. Allan, PhD, London Regional Cancer 
Program, London Health Sciences Centre, University of Western Ontario, 
London, ON

•	How Laser Scanning Cytometry Opened a Door to Study Cellular 
Inflammation and Apoptosis in Chronic Lung Disease - Andrew J. Halayko, PhD, 
Manitoba Institute of Child Health, Winnipeg, Manitoba

Day 3 – Tissue-Based Applications

•	Keynote presentation: Spatial Analysis of Hematopoietic Stem and 
Progenitor Cells in Bone Marrow – Leslie Silberstein, MD, Director, JPTM, 
Children's Hospital Boston, Dana-Farber Cancer Institute, Brigham and Women's 
Hospital, Harvard Medical School, Boston, MA

•	Function Follows Form: The Value of Morphology in the Cytometric 
Assessment of Cells and Tissues – William Geddie, MD, Department of 
Laboratory Medicine and Pathobiology, Toronto General Hospital, University 
Health Network, University of Toronto, ON

•	Laser Scanning Cytometry in Autism Research – Janine LaSalle, PhD, 
University of California at Davis, Davis, CA

•	Application of Laser Scanning Cytometry in Biomarker Drug 
Development: Challenges and Opportunities - Gloria Juan, PhD, Clinical 
Immunology, Amgen, Thousand Oaks, CA

•	Mapping of Tissue Architecture for Cells with Shorter Telomere 
Lengths – Alexei Protopopov, PhD, Center for Applied Cancer Science, Dana-
Farber Cancer Institute, Harvard Medical School, Boston, MA

•	Evaluation of Mitochondria and Peroxisomes in Single Cells and Tissue 
Sections Using Quantitative Imaging Cytometry – David Krull, GlaxoSmithKline 
Safety Assessment, Research Triangle Park, NC

Afternoon practical hands-on sessions:
•	Designing high-content quantitative imaging cytometry experiments – 
Raffi Manoukian, CompuCyte Corporation, William Telford, NIH and Andrea 
Holme, National University of Singapore 

•	Multi-color solid-phase cell cycle analysis (adherent cells) – Lead 
instructors:  James Jacobberger, Tammy Stephan, Case Comprehensive Cancer 
Center, Cleveland OH

•	Multi-color fluorescent and chromatic tissue analysis – David Krull, 
GlaxoSmithKline Safety Assessment, Research Triangle Park, NC

•	Biomarker validation/ FNA studies – Gloria Juan, Amgen, Thousand 
Oaks, CA 

•	FNA immunophenotyping - William Geddie, Princess Margaret Hospital, 
University of Toronto, ON